SCHEMBL24813192

SCHEMBL24813192

c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccc(-c3ccc4oc5ccc(-n6c7ccccc7c7ccccc76)cc5c4c3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HDAC4 P56524 1/20 0.39
PLA2G2A P14555 5/20 0.39
PLA2G4A P47712 5/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CASP3 P42574 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
PLA2G10 O15496 1/20 0.35
PRKDC P78527 3/20 0.35
PTPN1 P18031 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10038496 1.00 KDM4E (0.47) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL10041327 0.98 KDM4E (0.44) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL13383764 0.98 KDM4E (0.44) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL16804580 0.97 KDM4E (0.50) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL280420 0.97 KDM4E (0.46) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL15780991 0.97 KDM4E (0.46) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL2628401 0.97 KDM4E (0.46) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL2628328 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL9890115 0.95 KDM4E (0.42) KDM4EATML3MBTL1HDAC4PLA2G2A
SCHEMBL14868194 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027888-A1 ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KDM4E 3416/4885ATM 3436/4885L3MBTL1 1876/4885
US-20230027888-A1 ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND HTR1D, EHD1, HTR3D KDM4E 3361/4885ATM 3140/4885L3MBTL1 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.